búsquedas

Virología Clínica

Publicaciones

Número total de publicaciones en revistas científicas relevantes: 92
Número total de publicaciones revistas científicas relevantes en los últimos 5 años: 60
Factor de impacto global en los últimos 5 años: 240,848
H-index: 21

  • Mena A, Pedreira JD, Castro-Iglesias A, López S, Vázquez P, Poveda E. Metabolic syndorme is associated with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol 2013. Epub ahead of print.
  • Poveda E, García F. Telaprevir resistance. Enferm Infecc Microbiol Clin 2013; 31(Supl 3):26-32. Factor de Impacto JCR: 1,491
  • Barreiro P, Labarga P, Fernández-Montero JV, Poveda E, de Mendoza C, Sánchez C, Vispo E, Soriano V. Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy. J Clin Virol. 2013 Jul 30. doi:pii: S1386-6532(13)00263-1.10.1016/j.jcv.2013.06.031. [Epub ahead of print] PubMed PMID: 23910933. Factor de Impacto JCR: 3,969
  • Soriano V, Poveda E, Vispo E, Barreiro P. Hepatitis B in HIV-Infected Patients. Clin Liver Dis. 2013 Aug;17(3):489-501. doi: 10.1016/j.cld.2013.05.008. Epub 2013 Jul 8. PubMed PMID: 23905818. Factor de Impacto JCR: 3,180
  • Di Lello FA, Neukam K, Parra-Sanchez M, Plaza Z, Soriano V, Cifuentes C, Mira JA, Poveda E, Pineda JA. Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves. J Med Virol. 2013 Oct;85(10):1734-40. doi: 10.1002/jmv.23657. Epub 2013 Jul 16. PubMed PMID: 23861220. Factor de Impacto JCR: 2,820
  • Poveda E. Any risk for HIV patients posed by the novel influenza A (H7N9)? AIDS Rev. 2013 Apr-Jun;15(2):134-5. PubMed PMID: 23847792. Factor de Impacto JCR: 4,075
  • Soriano V, Vispo E, de Mendoza C, Labarga P, Plaza Z, Fernandez-Montero JV, Poveda E, Treviño A, Barreiro P. Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C. Antivir Ther. 2013 Jun 27. doi: 10.3851/IMP2659. [Epub ahead of print] PubMed PMID: 23804629. Factor de Impacto JCR: 3,161
  • Sánchez C, Plaza Z, Vispo E, de Mendoza C, Barreiro P, Fernández-Montero JV, Labarga P, Poveda E, Soriano V. Scaling up epidemics of acute hepatitis C andsyphilis in HIV-infected men who have sex with men in Spain. Liver Int. 2013 May 15. doi: 10.1111/liv.12212. [Epub ahead of print] PubMed PMID: 23730876. Factor de Impacto JCR: 3,824
  • Plaza Z, Aguilera A, Mena A, Vispo E, Sierra-Enguita R, Tomé S, Pedreira J, Rodriguez C, Barreiro P, Del Romero J, Soriano V, Poveda E. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B. AIDS. 2013 May 10. [Epub ahead of print] PubMed PMID: 23669158. Factor de Impacto JCR: 6,245
  • Soriano V, Vispo E, de Mendoza C, Labarga P, Fernandez-Montero JV, Poveda E, Treviño A, Barreiro P. Hepatitis C therapy with HCV NS5B polymerase inhibitors. Expert Opin Pharmacother. 2013 Jun;14(9):1161-70. doi:10.1517/14656566.2013.795543. Epub 2013 Apr 27. PubMed PMID: 23621117. Factor de Impacto JCR: 3,205
  • Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, Arts EJ, Quiñones-Mateu ME. Sensitive Cell-based Assay to Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism. J Clin Microbiol. 2013 Mar 13. [Epub ahead of print] PubMed PMID: 23486708. Factor de Impacto JCR: 4,15
  • Rivas P, Herrero MD, Poveda E, Madejón A, Treviño A, Gutiérrez M, Ladrón de Guevara C, Lago M, de Mendoza C, Soriano V, Puente S. Hepatitis B, C, and D and HIV Infections among Immigrants from Equatorial Guinea Living in Spain. Am J Trop Med Hyg. 2013 Jan 21. [Epub ahead of print] PubMed PMID: 23339201. Factor de Impacto JCR : 2,592
  • Meijide H, Mena A, Pernas B, Castro A, López S, Vázquez P, Bello J, Rodríguez-Martínez G, Pedreira JD. Malignances in HIV-infected patients: descriptive study of 129 cases between 1993 and 2010. Rev Chilena Infectol2013; 30:156-61. Factor de Impacto JCR: 0.43.
  • Soriano V, Labarga P, Fernández-Montero JV, Benito JM, Poveda E, Rallon N,Sánchez C, Vispo E, Barreiro P. The changing face of hepatitis C in the new era of direct-acting antivirals. Antiviral Res. 2012 Nov 9;97(1):36-40. doi:10.1016/j.antiviral.2012.10.011. [Epub ahead of print] PubMed PMID: 23147192. Factor de Impacto JCR: 4,301
  • Barreiro P, Vispo E, Poveda E, Fernández-Montero JV, Soriano V. Hepatitis C Therapy: Highlights From the 2012 Annual Meeting of the European Association for the Study of the Liver. Clin Infect Dis. 2012 Dec 12. [Epub ahead of print] PubMed PMID: 23090932. Factor de Impacto JCR: 8,186
  • Betancor G, Garriga C, Puertas MC, Nevot M, Anta L, Blanco JL, Pérez-Elías MJ, de Mendoza C, Martínez MA, Martinez-Picado J, Menéndez-Arias L; Resistance Platform of the Spanish AIDS Research Network (ResRIS), Iribarren JA, Caballero E, Ribera E, Llibre JM, Clotet B, Jaén A, Dalmau D, Gatel JM, Peraire J, Vidal F, Vidal C, Riera M, Córdoba J, López Aldeguer J, Galindo MJ, Gutiérrez F, Álvarez M, García F, Pérez-Romero P, Viciana P, Leal M, Palomares JC, Pineda JA, Viciana I, Santos J, Rodríguez P, Gómez Sirvent JL, Gutiérrez C, Moreno S, Pérez-Olmeda M, Alcamí J, Rodríguez C, del Romero J, Cañizares A, Pedreira J, Miralles C, Ocampo A, Morano L, Aguilera A, Garrido C, Manuzza G, Poveda E, Soriano V. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy. Retrovirology. 2012 Aug 13;9:68. doi: 10.1186/1742-4690-9-68. PubMed PMID: 22889300; PubMed Central PMCID: PMC3468358. Factor de Impacto JCR: 6,470
  • Anta L, Llibre JM, Poveda E, Blanco JL, Alvarez M, Pérez-Elías MJ, Aguilera A, Caballero E, Soriano V, de Mendoza C; on behalf of the Resistance Platform of the Spanish AIDS Research Network. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies. AIDS. 2013 Jan 2;27(1):81-85. PubMed PMID: 22842995. Factor de Impacto JCR: 6,245
  • Poveda E, Paredes R, Moreno S, Alcamí J, Córdoba J, Delgado R, Gutiérrez F, Llibre JM, García Deltoro M, Hernández-Quero J, Pulido F, Iribarren JA, García F. Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists. AIDS Rev. 2012 Jul;14(3):208-17. Review. PubMed PMID: 22833064. Factor de Impacto JCR: 4,075
  • Poveda E. Highly efficient transmission of prions by transfusions. AIDS Rev. 2012 Apr-Jun;14(2):218-9. Factor de Impacto JCR: 4,075
  • Martín-Carbonero L, Poveda E. Hepatitis B virus and HIV infection. Semin Liver Dis. 2012 May;32(2):114-9. doi: 10.1055/s-0032-1316466. Epub 2012 Jul 3. Review. PubMed PMID: 22760650. Factor de Impacto JCR: 7,053 21. Di Lello FA, Macias J, Plaza Z, García-Rey S, Soriano V, Cifuentes C, González Mdel M, Parra-Sánchez M, Labarga P, Recio E, Poveda E, Pineda JA. No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients. Antiviral Res. 2012 Aug;95(2):67-71. doi: 10.1016/j.antiviral.2012.05.016. Epub 2012 Jun 7. PubMed PMID: 22683722. Factor de Impacto JCR:3,161
  • Poveda E. Coinfection with Hepatitis B virus negatively impacts HIV disease progression. AIDS Rev. 2012 Jul-Sep;14(3):154-5. Factor de Impacto JCR: 4,075
  • Plaza Z, Soriano V, Vispo E, Del Mar Gonzalez M, Barreiro P, Seclén E, Poveda E. Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor. Antivir Ther. 2012 Mar 21. doi:10.3851/IMP2091. [Epub ahead of print] PubMed PMID: 22436385. Factor de Impacto JCR: 3,161
  • Martín-Carbonero L, Rallón NI, Benito JM, Poveda E, González-Lahoz J, Soriano V. Does Interleukin-28B Single Nucleotide Polymorphisms Influence the Natural History of Hepatitis B? AIDS Res Hum Retroviruses. 2012 Mar 23. [Epub ahead of print] PubMed PMID: 22324878. Factor de Impacto JCR: 2,246
cierre
Logotipo Servizo Galego de Saude Logotipo de Complexo Hospitalario Universitario A Coruña Logotipo Universidade da Coruña Logotipo Fundación do Complexo Hospitalario Universitario A Coruña Consellería de innovación